Back

A portuguese tale of Fabry disease, from 1611 to 2024

17 May 2025 (08:55 - 09:45)
Organised by: Logo
Congress Presentation Part of: Global epidemiology of heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Catarina Gregorio

Centro Hospitalar Universitário Lisboa Norte, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Lebanese heart failure registry (LHFR): baseline clinical characteristics
Professor H. Skouri (Beirut, LB)
Abstract Slides Video
Presentation thumbnail
Practical management of worsening heart failure and advanced heart failure: insights from a state-based heart failure network
Doctor C. Paitazoglou (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Global burden of heart failure in children and adolescents from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019
Doctor Z. Lai (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The impact of country income class on the worldwide variation in the diagnosis and management of HFpEF patients
Doctor I. Ingimarsdottir (Reykjavik, IS)
Abstract Slides Video
Presentation thumbnail
Impact of severe mitral regurgitation on patients with 'De Novo' heart failure and reduced ejection fraction: baseline characteristics and survival analysis
Mr O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Global epidemiology of heart failure

The Event

Event poster

Heart Failure 2025

17 May 2025 08:55 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling the silent threat: the cardiac burden of Fabry disease
30 August 2024
thumbnail
Congress Presentation
Follow-up of ATTR mutation carriers: the Portuguese experience
12 May 2024
thumbnail
Congress Presentation
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up
27 August 2023
thumbnail
Congress Presentation
Screening for Anderson-Fabry Disease in patients with left ventricular hypertrophy and disease-related red flags
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources